Filing Details

Accession Number:
0001209191-10-028402
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-05-17 13:00:00
Reporting Period:
2010-05-13
Filing Date:
2010-05-17
Accepted Time:
2010-05-17 21:39:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1087432 Intermune Inc ITMN Pharmaceutical Preparations (2834) 943296648
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1458451 Scott Seiwert 3280 Bayshore Blvd.
Brisbane CA 94005
Svp, Rsearch/ Preclinical Dev. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-05-14 625 $10.71 34,893 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The reporting person sold the noted securities in connection with the vesting of 625 shares on 5/13/10 (which represents a portion of the previously reported equity incentive grant made on 5/13/2008).